MIT Study Reveals Ketogenic Diets May Elevate Cancer Risk in the Small Intestine
A high-fat, low-carbohydrate diet, commonly known as a ketogenic diet, has been shown to assist some individuals in losing weight by shifting the body's energy source from sugar to fat. Recent research conducted by MIT scientists has brought to light potential health risks associated with this diet, particularly its effects on cancer risk in the small intestine. While previous studies suggested that ketogenic diets might offer protective benefits against colon cancer, the latest findings indicate an increased risk of cancer in the small intestine.
Omer Yilmaz, director of the MIT Stem Cell Initiative and a senior author of the study published in the journal Nature, emphasizes the need for caution when generalizing the effects of ketogenic diets across different tissues within the gastrointestinal tract. The study's lead authors, MIT postdocs Jessica Shay and Fangtao Chi, alongside contributions from other researchers, aimed to investigate whether ketogenic diets could similarly protect against intestinal cancer.
In their experiments, the researchers fed genetically predisposed mice either a ketogenic diet, a control diet, or a high fat/high calorie diet. The results revealed that mice on the ketogenic diet were more prone to developing tumors in the small intestine compared to those on the control diet. Notably, the mice did not become obese, yet their tumor development rates were comparable to those on a high fat/high calorie diet.
The study further explored the role of ketone bodies, which are produced when the body burns fat for energy. Contrary to expectations, the researchers found that ketone bodies did not contribute to tumor development. Instead, the growth of tumors was linked to how intestinal cells metabolize dietary fat through a process known as fatty acid oxidation. This metabolic pathway activates specific proteins that stimulate stem cell proliferation, which can increase the likelihood of some cells becoming cancerous.
While increased stem cell activity can be beneficial for repairing the intestinal lining after injury, excessive proliferation may lead to tumor formation. Interestingly, the ketogenic diet's effects were not uniform; while it promoted tumor growth in the small intestine, it suppressed tumor development in the colon, reinforcing the notion that the same dietary approach can have opposing effects in adjacent parts of the gastrointestinal tract.
The researchers aim to further investigate the underlying mechanisms that lead to these divergent outcomes in the colon and small intestine. Their findings underscore the importance of understanding the tissue-specific effects of ketogenic diets, especially as their popularity continues to rise. The implications of this research are significant, particularly in light of the increasing incidence of small intestinal tumors, which disproportionately affect individuals with genetic predispositions to intestinal cancer.
The study received funding from various sources, including the National Institutes of Health and the Koch Institute for Integrative Cancer Research. As the ketogenic diet remains a popular choice for weight management and potential longevity benefits, these findings highlight the necessity for careful consideration of its broader health implications.




